816 related articles for article (PubMed ID: 25924679)
1. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
[TBL] [Abstract][Full Text] [Related]
2. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
[TBL] [Abstract][Full Text] [Related]
3. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B;
Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579
[TBL] [Abstract][Full Text] [Related]
4. Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data.
van Oosten MJM; Logtenberg SJJ; Leegte MJH; Bilo HJG; Mohnen SM; Hakkaart-van Roijen L; Hemmelder MH; de Wit GA; Jager KJ; Stel VS
Nephrol Dial Transplant; 2020 Dec; 35(12):2138-2146. PubMed ID: 31598728
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease: the distribution of health care dollars.
St Peter WL; Khan SS; Ebben JP; Pereira BJ; Collins AJ
Kidney Int; 2004 Jul; 66(1):313-21. PubMed ID: 15200439
[TBL] [Abstract][Full Text] [Related]
6. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
Zhang H; Zhang C; Zhu S; Ye H; Zhang D
BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
[TBL] [Abstract][Full Text] [Related]
7. The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review.
Elshahat S; Cockwell P; Maxwell AP; Griffin M; O'Brien T; O'Neill C
PLoS One; 2020; 15(3):e0230512. PubMed ID: 32208435
[TBL] [Abstract][Full Text] [Related]
8. Predicting hospital costs for patients receiving renal replacement therapy to inform an economic evaluation.
Li B; Cairns J; Fotheringham J; Ravanan R;
Eur J Health Econ; 2016 Jul; 17(6):659-68. PubMed ID: 26153418
[TBL] [Abstract][Full Text] [Related]
9. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
[No Abstract] [Full Text] [Related]
10. Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs.
Chen PM; Lai TS; Chen PY; Lai CF; Yang SY; Wu V; Chiang CK; Kao TW; Huang JW; Chiang WC; Lin SL; Hung KY; Chen YM; Chu TS; Wu MS; Wu KD; Tsai TJ
Am J Med; 2015 Jan; 128(1):68-76. PubMed ID: 25149427
[TBL] [Abstract][Full Text] [Related]
11. Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease.
Ferguson TW; Tangri N; Rigatto C; Komenda P
Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):243-52. PubMed ID: 25661187
[TBL] [Abstract][Full Text] [Related]
12. Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.
Roggeri A; Roggeri DP; Zocchetti C; Bersani M; Conte F; ;
J Nephrol; 2017 Apr; 30(2):263-269. PubMed ID: 27165160
[TBL] [Abstract][Full Text] [Related]
13. Real-world costs of autosomal dominant polycystic kidney disease in the Nordics.
Eriksson D; Karlsson L; Eklund O; Dieperink H; Honkanen E; Melin J; Selvig K; Lundberg J
BMC Health Serv Res; 2017 Aug; 17(1):560. PubMed ID: 28806944
[TBL] [Abstract][Full Text] [Related]
14. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
[TBL] [Abstract][Full Text] [Related]
15. All-cause costs increase exponentially with increased chronic kidney disease stage.
Golestaneh L; Alvarez PJ; Reaven NL; Funk SE; McGaughey KJ; Romero A; Brenner MS; Onuigbo M
Am J Manag Care; 2017 Jun; 23(10 Suppl):S163-S172. PubMed ID: 28978205
[TBL] [Abstract][Full Text] [Related]
16. Economic burden of chronic kidney disease in Korea using national sample cohort.
Kim SH; Jo MW; Go DS; Ryu DR; Park J
J Nephrol; 2017 Dec; 30(6):787-793. PubMed ID: 28303461
[TBL] [Abstract][Full Text] [Related]
17. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
Goncalves GMR; Silva END
PLoS One; 2018; 13(10):e0203992. PubMed ID: 30273345
[TBL] [Abstract][Full Text] [Related]
18. Medical costs associated with chronic kidney disease progression in an Asian population with type 2 diabetes mellitus.
Low S; Lim SC; Zhang X; Wang J; Yeo SJD; Yeoh LY; Liu YL; Subramaniam T; Sum CF
Nephrology (Carlton); 2019 May; 24(5):534-541. PubMed ID: 30141833
[TBL] [Abstract][Full Text] [Related]
19. Perioperative outcomes of coronary artery bypass graft in renal transplant recipients in the United States: results from the Nationwide Inpatient Sample.
Tooley JE; Bohl DD; Kulkarni S; Rodriguez-Davalos MI; Mangi A; Mulligan DC; Yoo PS
Clin Transplant; 2016 Oct; 30(10):1258-1263. PubMed ID: 27440000
[TBL] [Abstract][Full Text] [Related]
20. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
